YPrime IRT in Action: Accelerating Global Cardiovascular Research

Managing large-scale, multi-country clinical trials with adaptive designs can sometimes push traditional IRT systems to their limits. When a leading pharmaceutical sponsor needed to support more than 5,000 high-risk cardiovascular patients across multiple cohorts, their legacy IRT system did not suffice.

This case study shows how YPrime’s industry-leading IRT solution transformed the sponsor’s clinical trial operations. The implementation eliminated weeks of delays while maintaining the highest standards of data integrity and regulatory compliance. The YPrime IRT platform’s ability to quickly support protocol adjustments and adaptive dosing strategies proved instrumental in managing this complex cardiovascular trial.

Key Takeaways

Discover how YPrime eliminated weeks of study delays by enabling rapid protocol amendments, accelerating the execution of this 5,000+ patient cardiovascular trial

Learn about the seamless integration of 10+ data systems that provided automated data exchange and real-time visibility across all trial operations

Explore the implementation of adaptive dosing strategies and automated drug supply monitoring that optimized site-level operations across 45+ countries

See how 24/7/365 multilingual support ensured consistent trial execution and enhanced site engagement across global locations

Get the Complete Case Study

Complete the form to see how YPrime IRT can deliver the same speed, flexibility, and certainty for you.